Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy

Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine Unive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2004-09, Vol.27 (9), p.2178-2183
Hauptverfasser: ZIEGLER, Dan, SOHR, Christoph G. H, NOUROOZ-ZADEH, Jaffar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2183
container_issue 9
container_start_page 2178
container_title Diabetes care
container_volume 27
creator ZIEGLER, Dan
SOHR, Christoph G. H
NOUROOZ-ZADEH, Jaffar
description Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany 2 Department of Medicine, University College Medical School, London, U.K Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de Abstract OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular autonomic neuropathy (CAN). RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85). RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased in the PN + /CAN − group compared with the control group (all P < 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P < 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P < 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent determinants. CONCLUSIONS —Oxidative stress is enhanced in diabetic patients
doi_str_mv 10.2337/diacare.27.9.2178
format Article
fullrecord <record><control><sourceid>gale_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16081820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A122532059</galeid><sourcerecordid>A122532059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</originalsourceid><addsrcrecordid>eNqFkluLEzEYhgdR3Fr9Ad5IEPRCmJrDZA6XpesJFlc8XA_fTL60WaZJN8lU-wv826bbwQUpSC4CyfN-xzfLnjO64EJUb5WBHjwueLVoFpxV9YNsxhohcymL-mE2o6xoctk0_CJ7EsINpbQo6vpxdsGkEKKo2Sz7ff3LKIhmj-Rb9BgCAavI0kbjjh82kkvUaAMSY8lXHBLqLImOxE1S4B69iQfiNLk00GE0PfnihoPF0bsdxM3hLtwKvDJuD6EfB_BkOUZn3Taxn_9yT7NHGoaAz6Z7nv14_-776mN-df3h02p5lfeyFDHvoQaue62oakSHpdZVp6UokdYVlryqWad4l1puKiUargBkxwBUWcqa1R2Iefb6FHfn3e2IIbZbE3ocBrDoxtCWZc15QYv_gqxJFGVVAl_-A9640dvURMu5oIVs0krmWX6C1jBga6x20UO_RoseBmdRm_S8ZJxLwak88oszfDoK09zOCthJ0HsXgkfd7rzZgj-0jLZHs7STWVpetU17NEvSvJgqH7stqnvF5I4EvJqAtDoYtAfbm3DPlTQNldPEvTlxG7Pe_DQpibpzA4YzWf8AjujZtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223045919</pqid></control><display><type>article</type><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</creator><creatorcontrib>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</creatorcontrib><description>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany 2 Department of Medicine, University College Medical School, London, U.K Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de Abstract OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular autonomic neuropathy (CAN). RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85). RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased in the PN + /CAN − group compared with the control group (all P &lt; 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P &lt; 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P &lt; 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent determinants. CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress, diabetes duration and triglyceride levels are also related to the severity of PN. CAN, cardiovascular autonomic neuropathy MNCV, motor nerve conduction velocity NIS-LL, Neuropathy Impairment Score of the Lower Limbs O2·−, superoxide anion ONOO−, peroxynitrite PGF, prostaglandin F PN, polyneuropathy SIN-1, 3-morpholino-sydnonimine HCl TPT, thermal perception threshold VPT, vibration perception threshold Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted June 15, 2004. Received January 12, 2004. DIABETES CARE</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.27.9.2178</identifier><identifier>PMID: 15333481</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Adult ; Antioxidants ; Antioxidants - metabolism ; Ascorbic Acid - blood ; Autonomic Nervous System Diseases - blood ; Autonomic Nervous System Diseases - physiopathology ; Autonomic neuropathies ; Biological and medical sciences ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - physiopathology ; Care and treatment ; Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction ; Diabetes ; Diabetes. Impaired glucose tolerance ; Diabetic Neuropathies - blood ; Diabetic Neuropathies - physiopathology ; Diabetics ; Diagnosis ; Dinoprost - analogs &amp; derivatives ; Dinoprost - blood ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Female ; Free radicals ; Humans ; Male ; Medical sciences ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurological disorders ; Neurology ; Oxidative Stress - physiology ; Reference Values</subject><ispartof>Diabetes care, 2004-09, Vol.27 (9), p.2178-2183</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 American Diabetes Association</rights><rights>Copyright American Diabetes Association Sep 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</citedby><cites>FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16081820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15333481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZIEGLER, Dan</creatorcontrib><creatorcontrib>SOHR, Christoph G. H</creatorcontrib><creatorcontrib>NOUROOZ-ZADEH, Jaffar</creatorcontrib><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany 2 Department of Medicine, University College Medical School, London, U.K Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de Abstract OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular autonomic neuropathy (CAN). RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85). RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased in the PN + /CAN − group compared with the control group (all P &lt; 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P &lt; 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P &lt; 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent determinants. CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress, diabetes duration and triglyceride levels are also related to the severity of PN. CAN, cardiovascular autonomic neuropathy MNCV, motor nerve conduction velocity NIS-LL, Neuropathy Impairment Score of the Lower Limbs O2·−, superoxide anion ONOO−, peroxynitrite PGF, prostaglandin F PN, polyneuropathy SIN-1, 3-morpholino-sydnonimine HCl TPT, thermal perception threshold VPT, vibration perception threshold Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted June 15, 2004. Received January 12, 2004. DIABETES CARE</description><subject>Adult</subject><subject>Antioxidants</subject><subject>Antioxidants - metabolism</subject><subject>Ascorbic Acid - blood</subject><subject>Autonomic Nervous System Diseases - blood</subject><subject>Autonomic Nervous System Diseases - physiopathology</subject><subject>Autonomic neuropathies</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Care and treatment</subject><subject>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</subject><subject>Diabetes</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Neuropathies - blood</subject><subject>Diabetic Neuropathies - physiopathology</subject><subject>Diabetics</subject><subject>Diagnosis</subject><subject>Dinoprost - analogs &amp; derivatives</subject><subject>Dinoprost - blood</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Free radicals</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurological disorders</subject><subject>Neurology</subject><subject>Oxidative Stress - physiology</subject><subject>Reference Values</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkluLEzEYhgdR3Fr9Ad5IEPRCmJrDZA6XpesJFlc8XA_fTL60WaZJN8lU-wv826bbwQUpSC4CyfN-xzfLnjO64EJUb5WBHjwueLVoFpxV9YNsxhohcymL-mE2o6xoctk0_CJ7EsINpbQo6vpxdsGkEKKo2Sz7ff3LKIhmj-Rb9BgCAavI0kbjjh82kkvUaAMSY8lXHBLqLImOxE1S4B69iQfiNLk00GE0PfnihoPF0bsdxM3hLtwKvDJuD6EfB_BkOUZn3Taxn_9yT7NHGoaAz6Z7nv14_-776mN-df3h02p5lfeyFDHvoQaue62oakSHpdZVp6UokdYVlryqWad4l1puKiUargBkxwBUWcqa1R2Iefb6FHfn3e2IIbZbE3ocBrDoxtCWZc15QYv_gqxJFGVVAl_-A9640dvURMu5oIVs0krmWX6C1jBga6x20UO_RoseBmdRm_S8ZJxLwak88oszfDoK09zOCthJ0HsXgkfd7rzZgj-0jLZHs7STWVpetU17NEvSvJgqH7stqnvF5I4EvJqAtDoYtAfbm3DPlTQNldPEvTlxG7Pe_DQpibpzA4YzWf8AjujZtw</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>ZIEGLER, Dan</creator><creator>SOHR, Christoph G. H</creator><creator>NOUROOZ-ZADEH, Jaffar</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</title><author>ZIEGLER, Dan ; SOHR, Christoph G. H ; NOUROOZ-ZADEH, Jaffar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-ca8a2fcfd0d93be6ff7bf536e087e62781bd2b59997d392daa5b1aad665818ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antioxidants</topic><topic>Antioxidants - metabolism</topic><topic>Ascorbic Acid - blood</topic><topic>Autonomic Nervous System Diseases - blood</topic><topic>Autonomic Nervous System Diseases - physiopathology</topic><topic>Autonomic neuropathies</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Care and treatment</topic><topic>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</topic><topic>Diabetes</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Neuropathies - blood</topic><topic>Diabetic Neuropathies - physiopathology</topic><topic>Diabetics</topic><topic>Diagnosis</topic><topic>Dinoprost - analogs &amp; derivatives</topic><topic>Dinoprost - blood</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Free radicals</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurological disorders</topic><topic>Neurology</topic><topic>Oxidative Stress - physiology</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZIEGLER, Dan</creatorcontrib><creatorcontrib>SOHR, Christoph G. H</creatorcontrib><creatorcontrib>NOUROOZ-ZADEH, Jaffar</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agriculture Science Database</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>ProQuest Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZIEGLER, Dan</au><au>SOHR, Christoph G. H</au><au>NOUROOZ-ZADEH, Jaffar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>27</volume><issue>9</issue><spage>2178</spage><epage>2183</epage><pages>2178-2183</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy Dan Ziegler , MD 1 , Christoph G.H. Sohr , CAND MED 1 and Jaffar Nourooz-Zadeh , PHD 2 1 German Diabetes Research Institute, Leibniz Institute, Heinrich Heine University, Düsseldorf, Germany 2 Department of Medicine, University College Medical School, London, U.K Address correspondence and reprint requests to Prof. Dr. Dan Ziegler, Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225 Düsseldorf, Germany. E-mail: dan.ziegler{at}ddfi.uni-duesseldorf.de Abstract OBJECTIVE —Oxidative stress resulting from enhanced free-radical formation and/or a defect in antioxidant defenses has been implicated in the pathogenesis of experimental diabetic neuropathy. The objective of this study was to evaluate plasma levels of various biomarkers of oxidative stress in diabetic subjects in relation to the presence or absence of polyneuropathy (PN) and/or cardiovascular autonomic neuropathy (CAN). RESEARCH DESIGN AND METHODS —Plasma 8-iso-prostaglandin F 2α (8-iso-PGF 2α ), superoxide anion (O 2 ·− ) generation, lag phase to peroxidation by peroxynitrite (ONOO − ), vitamin E-to-lipid ratio, and vitamin C were measured in nonsmoking diabetic patients without PN and CAN (PN − /CAN − group; n = 62), in a group with PN but without CAN (PN + /CAN − group; n = 105), in those with both PN and CAN (PN + /CAN + group; n = 22), and in healthy control subjects ( n = 85). RESULTS —All three markers of oxidative stress were significantly increased, and both markers of antioxidant defense were decreased in the PN + /CAN − group compared with the control group (all P &lt; 0.05). PN − /CAN − subjects showed a significant increase compared with control subjects for 8-iso-PGF 2α , O 2 ·− , and ONOO − and a decrease for the vitamin E-to-lipid ratio (all P &lt; 0.05). In the PN + /CAN − group, a significant increase compared with the PN − /CAN − group was noted for O 2 ·− , whereas the vitamin E-to-lipid ratio and vitamin C were reduced (all P &lt; 0.05). No significant differences were noted between the PN + /CAN − and PN + /CAN + groups for each of the five markers of oxidative stress. In multivariate models, O 2 ·− and ONOO − were independently associated with neuropathic deficits, but diabetes duration and triglyceride levels were also independent determinants. CONCLUSIONS —Oxidative stress is enhanced in diabetic patients before the development of PN but to an even higher degree in those with PN, without further significant increase in relation to superimposed autonomic neuropathy. However, apart from oxidative stress, diabetes duration and triglyceride levels are also related to the severity of PN. CAN, cardiovascular autonomic neuropathy MNCV, motor nerve conduction velocity NIS-LL, Neuropathy Impairment Score of the Lower Limbs O2·−, superoxide anion ONOO−, peroxynitrite PGF, prostaglandin F PN, polyneuropathy SIN-1, 3-morpholino-sydnonimine HCl TPT, thermal perception threshold VPT, vibration perception threshold Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted June 15, 2004. Received January 12, 2004. DIABETES CARE</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>15333481</pmid><doi>10.2337/diacare.27.9.2178</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2004-09, Vol.27 (9), p.2178-2183
issn 0149-5992
1935-5548
language eng
recordid cdi_pascalfrancis_primary_16081820
source MEDLINE; Free E-Journal (出版社公開部分のみ)
subjects Adult
Antioxidants
Antioxidants - metabolism
Ascorbic Acid - blood
Autonomic Nervous System Diseases - blood
Autonomic Nervous System Diseases - physiopathology
Autonomic neuropathies
Biological and medical sciences
Cardiovascular Diseases - blood
Cardiovascular Diseases - physiopathology
Care and treatment
Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction
Diabetes
Diabetes. Impaired glucose tolerance
Diabetic Neuropathies - blood
Diabetic Neuropathies - physiopathology
Diabetics
Diagnosis
Dinoprost - analogs & derivatives
Dinoprost - blood
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Female
Free radicals
Humans
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Neurological disorders
Neurology
Oxidative Stress - physiology
Reference Values
title Oxidative Stress and Antioxidant Defense in Relation to the Severity of Diabetic Polyneuropathy and Cardiovascular Autonomic Neuropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxidative%20Stress%20and%20Antioxidant%20Defense%20in%20Relation%20to%20the%20Severity%20of%20Diabetic%20Polyneuropathy%20and%20Cardiovascular%20Autonomic%20Neuropathy&rft.jtitle=Diabetes%20care&rft.au=ZIEGLER,%20Dan&rft.date=2004-09-01&rft.volume=27&rft.issue=9&rft.spage=2178&rft.epage=2183&rft.pages=2178-2183&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.27.9.2178&rft_dat=%3Cgale_pasca%3EA122532059%3C/gale_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223045919&rft_id=info:pmid/15333481&rft_galeid=A122532059&rfr_iscdi=true